The results demonstrated that CAFs cause infiltration of MOs via the CXCL12/CXCR4 pathway followed by their differentiation to M2 phenotype, which implies the potential of CXCL12-mediated macrophage recruitment as a novel target for cancer therapy (71). This evidence concerns the gene CXCL12 and cancer.